SEVELAMER DR.REDDY'S, SEVELAMER-REDDY'S, SEVELAMER-DRLA, SEVELAMER-RZ (Dr Reddys Laboratories Australia Pty Ltd)
Product name
SEVELAMER DR.REDDY'S, SEVELAMER-REDDY'S, SEVELAMER-DRLA, SEVELAMER-RZ
Date registered
Evaluation commenced
Decision date
Approval time
249 working days (255)
Active ingredients
sevelamer carbonate
Registration type
New generic medicine
Indication
SEVELAMER DR.REDDY'S, SEVELAMER-REDDY'S, SEVELAMER-DRLA, SEVELAMER-RZ (tablets) is indicated in the management of hyperphosphataemia in adults patients with stage 4 and 5 chronic kidney disease.